NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X902. A total of 3 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 100 | -98.7% | 0.00% | – |
| Q2 2022 | $6,000 | -53.8% | 7,700 | -54.7% | 0.00% | – |
| Q1 2022 | $13,000 | -27.8% | 17,000 | -4.0% | 0.00% | – |
| Q4 2021 | $18,000 | -59.1% | 17,700 | -29.8% | 0.00% | – |
| Q3 2021 | $44,000 | -36.2% | 25,200 | -33.2% | 0.00% | – |
| Q2 2021 | $69,000 | +176.0% | 37,700 | +199.2% | 0.00% | – |
| Q1 2021 | $25,000 | -76.2% | 12,600 | -74.2% | 0.00% | – |
| Q4 2020 | $105,000 | +238.7% | 48,800 | +320.7% | 0.00% | – |
| Q3 2020 | $31,000 | -49.2% | 11,600 | -25.2% | 0.00% | – |
| Q2 2020 | $61,000 | +56.4% | 15,500 | -69.8% | 0.00% | – |
| Q1 2020 | $39,000 | -39.1% | 51,300 | +1.4% | 0.00% | – |
| Q4 2019 | $64,000 | – | 50,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 7,700 | $6,000 | 0.00% |
| SIMPLEX TRADING, LLC | 19,800 | $14,000 | 0.00% |